Home › Funds › ACUTA CAPITAL PARTNERS, LLC › AVBP
ACUTA CAPITAL PARTNERS, LLC position in AVBP
ARRIVENT BIOPHARMA INC COM · Health Care
ACUTA CAPITAL PARTNERS, LLC reported holding 218,694 shares of AVBP (ARRIVENT BIOPHARMA INC COM) in its Q2 2026 13F filing — a position valued at US$7.6M, representing 5.29% of its reported portfolio and ranking #5 among its reported holdings. ACUTA CAPITAL PARTNERS, LLC first reported this position in Q2 2026.
Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR
How ACUTA CAPITAL PARTNERS, LLC's AVBP position evolved
ACUTA CAPITAL PARTNERS, LLC first disclosed a stake in AVBP in Q2 2026 at 218,694 shares (US$7.6M).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q2 2026 | 218.69K | $7.60M | New |
About AVBP and 13F data
AVBP (ARRIVENT BIOPHARMA INC COM) is a Health Care company. 60 other funds we track also report a position in AVBP — the largest reported positions include MONTANOVA CAPITAL, LLC (US$156.9M), INFINITUM ASSET MANAGEMENT, LLC (US$154.2M), Hillhouse Capital (HHLR Advisors) (US$136.5M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding AVBP
- MONTANOVA CAPITAL, LLC 4.52M sh · $156.87M · Q2 2026
- INFINITUM ASSET MANAGEMENT, LLC 4.44M sh · $154.19M · Q2 2026
- Hillhouse Capital (HHLR Advisors) 3.93M sh · $136.50M · Q2 2026
- ORBIMED ADVISORS LLC 3.03M sh · $105.17M · Q2 2026
- Octagon Capital Advisors LP 1.97M sh · $68.47M · Q2 2026
- Sofinnova Investments, Inc. 1.70M sh · $58.95M · Q2 2026
- Vivo Capital, LLC 1.68M sh · $58.44M · Q2 2026
- Novo Holdings A/S 1.50M sh · $52.11M · Q2 2026
- General Catalyst Group Management, LLC 1.49M sh · $51.93M · Q2 2026
- Logos Global Management LP 1.00M sh · $34.74M · Q2 2026
- HSG Holding Ltd 663.31K sh · $23.04M · Q2 2026
- Foresite Capital Management VI LLC 301.34K sh · $10.47M · Q2 2026
More on ACUTA CAPITAL PARTNERS, LLC
FAQ
How long has ACUTA CAPITAL PARTNERS, LLC held AVBP?
ACUTA CAPITAL PARTNERS, LLC has disclosed AVBP holdings in 1 of the last 1 reported quarters, going back to Q2 2026.
What is ACUTA CAPITAL PARTNERS, LLC's current position in AVBP?
As of Q2 2026, ACUTA CAPITAL PARTNERS, LLC holds 218.69K shares of AVBP (ARRIVENT BIOPHARMA INC COM), valued at $7.60M, representing 5.29% of its reported portfolio and ranking #5.
Has ACUTA CAPITAL PARTNERS, LLC been buying or selling AVBP?
In the latest 13F filing (Q2 2026), ACUTA CAPITAL PARTNERS, LLC newly opened its position in AVBP.
Which other funds hold AVBP?
Other major institutional holders of AVBP include MONTANOVA CAPITAL, LLC, INFINITUM ASSET MANAGEMENT, LLC, Hillhouse Capital (HHLR Advisors), among 60 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.